Hymecromone: Difference between revisions
Created page with "{{Drugbox | Watchedfields = changed | verifiedrevid = 443864211 | IUPAC_name = 7-Hydroxy-4-methylchromen-2-one | image = Hymecromone.png <!--Clinical data--> | tradename =..." |
m Protected "Hymecromone": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(One intermediate revision by one other user not shown) | |||
Line 57: | Line 57: | ||
| synonyms = 4-Methylumbelliferone | | synonyms = 4-Methylumbelliferone | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
'''Hymecromone''' (4-methylumbelliferone) is a drug used in [[bile]] therapy. It is used as | ==Overview== | ||
'''Hymecromone''' (4-methylumbelliferone) is a drug used in [[bile]] therapy. It is used as choleretic and [[antispasmodic]] drugs and as a standard for the fluorometric determination of enzyme activity. | |||
Hymecromone is a crystalline solid with a melting point of 194–195 °C. It is soluble in [[methanol]] and [[glacial acetic acid]]. | Hymecromone is a crystalline solid with a melting point of 194–195 °C. It is soluble in [[methanol]] and [[glacial acetic acid]]. | ||
==References== | |||
{{ | {{Reflist|2}} | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Phenols]] | [[Category:Phenols]] | ||
Latest revision as of 16:29, 20 August 2015
Clinical data | |
---|---|
Synonyms | 4-Methylumbelliferone |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C10H8O3 |
Molar mass | 176.17 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Hymecromone |
Articles |
---|
Most recent articles on Hymecromone Most cited articles on Hymecromone |
Media |
Powerpoint slides on Hymecromone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Hymecromone at Clinical Trials.gov Clinical Trials on Hymecromone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Hymecromone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Hymecromone Discussion groups on Hymecromone Patient Handouts on Hymecromone Directions to Hospitals Treating Hymecromone Risk calculators and risk factors for Hymecromone
|
Healthcare Provider Resources |
Causes & Risk Factors for Hymecromone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hymecromone (4-methylumbelliferone) is a drug used in bile therapy. It is used as choleretic and antispasmodic drugs and as a standard for the fluorometric determination of enzyme activity.
Hymecromone is a crystalline solid with a melting point of 194–195 °C. It is soluble in methanol and glacial acetic acid.